{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:12:24Z","timestamp":1785247944288,"version":"3.55.0"},"reference-count":27,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Feline Medicine and Surgery Open Reports"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>A 16-year-old, spayed female domestic shorthair cat was referred to the Schwarzman Animal Medical Center for evaluation of chronic, progressive eosinophilia accompanied by vomiting and weight loss despite normal appetite. Blood smear evaluation revealed immature eosinophils with dysplastic features and occasional giant forms. Abdominal ultrasound identified small-intestinal thickening, a hepatopathy and splenomegaly. Screening for feline leukemia virus, feline immunodeficiency virus and heartworm infection were negative. Chronic eosinophilic leukemia was suspected, although hypereosinophilic syndrome could not be ruled out. At the time of referral, the cat was receiving prednisolone and chlorambucil for suspected small cell gastrointestinal lymphoma, but showed persistent clinical signs and progressive eosinophilia. Chlorambucil was discontinued and toceranib was initiated alongside prednisolone. No adverse effects attributable to toceranib were observed. A partial response, defined as resolution of clinical signs and a 30% reduction in circulating eosinophils, was observed on day 39. A subsequent progression-free survival interval of 4 weeks was achieved. Progressive disease developed on day 75, and given declining quality of life, euthanasia was thereby elected on day 89.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Relevance and novel information<\/jats:title>\n                    <jats:p>This case report is the first to describe the use of toceranib to treat suspected chronic eosinophilic leukemia, a rare and poorly documented disease process in cats. This novel therapeutic approach is the first publication of a partial response and stable disease in the treatment of suspected chronic eosinophilic leukemia in a cat.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20551169261460751","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:57:17Z","timestamp":1780718237000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Suspected chronic eosinophilic leukemia in a cat treated with toceranib"],"prefix":"10.1177","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9432-7991","authenticated-orcid":false,"given":"Cristian","family":"Mastrangelo","sequence":"first","affiliation":[{"name":"Schwarzman Animal Medical Center, Department of Medical Oncology, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Siegel","sequence":"additional","affiliation":[{"name":"IDEXX Reference Laboratory, Schwarzman Animal Medical, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Carruth","sequence":"additional","affiliation":[{"name":"Schwarzman Animal Medical Center, Department of Medical Oncology, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Leibman","sequence":"additional","affiliation":[{"name":"Schwarzman Animal Medical Center, Department of Medical Oncology, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"e_1_3_2_2_2","first-page":"349","article-title":"Eosinophilia in the cat: a retrospective study of 312 cases (1975\u20131986).","volume":"26","author":"Center SA","year":"1990","unstructured":"Center SA, Randolph JF, Erb HN, et al. Eosinophilia in the cat: a retrospective study of 312 cases (1975\u20131986). J Am Anim Hosp Assoc 1990; 26: 349\u2013358.","journal-title":"J Am Anim Hosp Assoc"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/0300985810389317"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfms.2007.05.004"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-165X.2006.tb00164.x"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/9781119500537.ch46"},{"key":"e_1_3_2_7_2","first-page":"183","volume-title":"Veterinary hematology, clinical chemistry and cytology e-book","author":"Thrall MA.","year":"2022","unstructured":"Thrall MA. Lymphoproliferative disorders and myeloid neoplasms. In: Thrall MA, Weiser G, Allison RW, et al (eds). Veterinary hematology, clinical chemistry and cytology e-book. 3rd ed. Wiley-Blackwell, 2022, pp. 183\u2013200.","edition":"3"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/9781119500537.ch66"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26966"},{"key":"e_1_3_2_10_2","first-page":"7","article-title":"Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans.","volume":"122","author":"Breen M","year":"2008","unstructured":"Breen M, Modiano JF. Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans. Vet Immunol Immunopathol 2008; 122: 7\u201315.","journal-title":"Vet Immunol Immunopathol"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.2002.tb00091.x"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00049"},{"key":"e_1_3_2_13_2","article-title":"Marked paraneoplastic basophilia accompanying eosinophilia in a cat with alimentary T-cell lymphoma.","volume":"3","author":"Balan M","year":"2017","unstructured":"Balan M, Hope A, Cassidy J, et al. Marked paraneoplastic basophilia accompanying eosinophilia in a cat with alimentary T-cell lymphoma. JFMS Open Rep 2017; 3: 2055116917730180.","journal-title":"JFMS Open Rep"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.1985.46.05.1066"},{"key":"e_1_3_2_15_2","first-page":"248","article-title":"Hypereosinophilic syndrome in cats: a report of three cases.","volume":"49","author":"McEwen SA","year":"1985","unstructured":"McEwen SA, Valli VE, Hulland TJ. Hypereosinophilic syndrome in cats: a report of three cases. Can J Comp Med 1985; 49: 248\u2013253.","journal-title":"Can J Comp Med"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.16690"},{"key":"e_1_3_2_17_2","first-page":"679","article-title":"Hypereosinophilic syndrome in a cat.","volume":"37","author":"Wilson SC","year":"1996","unstructured":"Wilson SC, Thomson-Kerr K, Houston DM. Hypereosinophilic syndrome in a cat. Can Vet J 1996; 37: 679\u2013680.","journal-title":"Can Vet J"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.70.1085"},{"key":"e_1_3_2_19_2","first-page":"139","article-title":"Three cases of feline hypereosinophilic syndrome treated with imatinib mesilate.","volume":"49","author":"Cochet-Faivre N","year":"2014","unstructured":"Cochet-Faivre N, Prelaud P, Bensignor E, et al. Three cases of feline hypereosinophilic syndrome treated with imatinib mesilate. Rev V\u00e9t Clin 2014; 49: 139\u2013144.","journal-title":"Rev V\u00e9t Clin"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8906"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19853"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2018.1425142"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2003.10.006"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.3390\/ani13193059"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2005.tb02778.x"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/vco.12211"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X241256473"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X16643124"}],"container-title":["Journal of Feline Medicine and Surgery Open Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20551169261460751","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20551169261460751","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20551169261460751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:46:21Z","timestamp":1785246381000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20551169261460751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1177\/20551169261460751"],"URL":"https:\/\/doi.org\/10.1177\/20551169261460751","relation":{},"ISSN":["2055-1169","2055-1169"],"issn-type":[{"value":"2055-1169","type":"print"},{"value":"2055-1169","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"article-number":"20551169261460751"}}